Dexrazoxane Injection, Powder, Lyophilized, For Solution
Product Images NDC 72611-716

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dexrazoxane (NDC 72611-716). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Almaject, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Carton (Carton)
Dexrazoxane for Injection 500 mg/vial lyophilized powder for solution intravenous use. Single-dose vial labeled for sterile, pyrogen-free product. Packaging includes dosage instructions, storage conditions, and manufacturer details: Gland Pharma Limited, India, and Almaject, Inc., Morristown, NJ. The label shows NDC 72611-716-72 and features a blue circular emblem highlighting the strength.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
Bar chart showing the number of patients versus cumulative dose of doxorubicin (mg/m²) for two treatment groups: FAC/Dexrazoxane and FAC. The chart displays patient counts decreasing as the cumulative dose increases, with FAC/Dexrazoxane group generally having higher patient numbers at higher doses compared to the FAC group.*
FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Dexrazoxane, showing its two cyclic imide rings connected by a methylene bridge with a chiral center and a methyl group attached.*
FDA Label Image

Vial-label (Vial Label)

Vial-label (Vial Label)
Label for Dexrazoxane for Injection 500 mg vial in lyophilized powder form for intravenous use. It is a single-dose, sterile, pyrogen-free vial labeled for intravenous use only. The label includes storage, reconstitution instructions, manufacturer Almaject, Inc., NDC 72611-716, a barcode, lot and expiration date fields, and mentions adjustment of pH and specific reconstitution directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.